In-person AND virtual! – We pioneered a new conference format that connected in-person and virtual audiences to create a unique experience. Matching the innovation that comes through our members’ work, ISPOR pushed the boundaries of innovation to design an event that worked in today’s quickly changing environment.

While the live portion of ISPOR Europe 2022 is now over, you may still register for the virtual only portion. Gain access to nearly all in-person and virtual content available on-demand as well as ISPOR’s robust virtual platform which includes networking and posters. Register today!

On-demand session recordings as well as virtual posters and networking will be available through 9 December 2022. 

Download the program guide

Developments in the Use of Health Economics and Outcomes Research to Improve Enrollment and Retention in Clinical Trials

Speaker(s)

Kimberley Kallsen, PhD, Boehringer Ingelheim, 55218 Schwabenheim, Germany, Kevin Patrick Marsh, PhD, Evidera, London, LON, UK, Zachary Peter Smith, -, Tufts University School of Medicine, Henderson, NV, USA and Maureen Rutten-van Mölken, PhD, Erasmus University Rotterdam, Rotterdam, ZH, Netherlands

Purpose: This session will summarize and illustrate how the health economics and outcomes research (HEOR) community is supporting the design and implementation of clinical studies and how this is improving enrolment and retention.

Outline: Engaging patients in the design of clinical trials has been demonstrated to improve enrollment and retention. To date this has often been limited to engagement with small, non-representative samples of patients. However, recent efforts have enabled the insights of HEOR to be applied to the design of clinical studies. After summarizing the state of the art in engaging patients in clinical study design, the session will illustrate how HEOR is enabling study design optimization. The development of a patient study experience instrument will be covered as well as recent applications of preference methods to understand how study design impacts patients’ willingness to participate in studies. The use of both experience instruments and preference data to improve study design will be described.

Code

317